Literature DB >> 15663185

Time course studies on the functional evaluation of experimental chronic myocardial infarction in rats.

Panchatcharam Manikandan1, Miriyala Sumitra, Mohammed Nayeem, Bhakthavatsalam Murali Manohar, Beema Lokanadam, Subbiah Vairamuthu, Samu Subramaniam, Rengarajulu Puvanakrishnan.   

Abstract

In vivo models of myocardial infarction induced by coronary artery ligation (CAL) in rats usually suffer from high early mortality and a low rate of induction. This study investigated the time course initiation of chronic myocardial infarction (CMI) in albino rats and the possibility of reducing early mortality rate due to myocardial infarction by modification of the surgical technique. CAL was carried out by passing the suture through the epicardial layer around the midway of the left anterior descending coronary artery including a small area of the myocardium to avoid mechanical damage to the heart geometry. In addition, the role of endothelin-1 (ET-1) in rat heart with congestive heart failure was critically assessed. Time course initiation experiments were designed by sacrificing the animals at different time intervals and by carrying out physiological, biochemical, histopathological, electron microscopical and immunohistochemical studies. Specific markers of myocardial injury, viz. cardiac troponin-T (cTnT), high sensitivity C-reactive protein, lactate dehydrogenase and fibrinogen were measured at different time points. Serum marker enzymes and activities of lysosomal hydrolases were found to be elevated on the eighth day post-ligation. Histopathological studies demonstrated focal areas showing fibrovascular tissue containing fibroblasts, collagenous ground substance and numerous small capillaries replacing cardiac muscle fibers. Transmission electron micrographs exhibited mitochondrial changes of well-developed irreversible cardiac injury, viz. swelling, disorganization of cristae, appearance of mitochondrial amorphous matrix densities, significant distortion of muscle fibers and distinct disruption of the intercalated discs. Immunoblotting studies confirmed the presence of alpha 2-macroglobulin which supported the inflammatory response. The severity of the CMI was inferred by the measurement of the level of ET-1 in plasma and left ventricle which was significantly higher in the CMI rats than in the sham-operated rats. Immunohistochemical studies at different time intervals showed that there was a significant immunoexpression of ET-1 on the eighth day post-ligation. This study conclusively showed that ligation of left anterior descending artery minimized mortality and ET-1 was expressed during CMI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663185     DOI: 10.1023/b:mcbi.0000049364.56230.ea

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

1.  Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.

Authors:  P Mulder; V Richard; G Derumeaux; M Hogie; J P Henry; F Lallemand; P Compagnon; B Macé; E Comoy; B Letac; C Thuillez
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Cathepsin D activity in normal and osteoarthritic human cartilage.

Authors:  A I Sapolsky; R D Altman; D S Howell
Journal:  Fed Proc       Date:  1973-04

3.  Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status.

Authors:  M Sumitra; P Manikandan; D A Kumar; N Arutselvan; K Balakrishna; B M Manohar; R Puvanakrishnan
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

4.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 5.  Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

6.  Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload.

Authors:  R Yorikane; S Sakai; T Miyauchi; T Sakurai; Y Sugishita; K Goto
Journal:  FEBS Lett       Date:  1993-10-11       Impact factor: 4.124

7.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

Authors:  M C Fishbein; S Meerbaum; J Rit; U Lando; K Kanmatsuse; J C Mercier; E Corday; W Ganz
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

8.  Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro.

Authors:  T Suzuki; T Kumazaki; Y Mitsui
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

9.  Impact of increased infarct transmurality on remodeling and function during healing after anterior myocardial infarction in the dog.

Authors:  B I Jugdutt; M I Khan
Journal:  Can J Physiol Pharmacol       Date:  1992-07       Impact factor: 2.273

10.  Concentration time courses of troponin and myosin subunits after acute myocardial infarction.

Authors:  J Mair; B Thome-Kromer; I Wagner; P Lechleitner; F Dienstl; B Puschendorf; G Michel
Journal:  Coron Artery Dis       Date:  1994-10       Impact factor: 1.439

View more
  2 in total

1.  A novel tetrapeptide derivative exhibits in vitro inhibition of neutrophil-derived reactive oxygen species and lysosomal enzymes release.

Authors:  Sumitra Miriyala; Manikandan Panchatcharam; Meera Ramanujam; Rengarajulu Puvanakrishnan
Journal:  Oxid Med Cell Longev       Date:  2013-05-30       Impact factor: 6.543

2.  Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of stem cell therapy.

Authors:  G Srikanth; P Prakash; N Tripathy; M Dikshit; S Nityanand
Journal:  J Stem Cells Regen Med       Date:  2009-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.